Modulation of NKG2D

Details for Australian Patent Application No. 2005231478 (hide)

Owner The Regents of the University of California

Inventors Ogasawara, Koetsu; Lanier, Lewis L.; Bluestone, Jeffrey A.

Agent Pizzeys

Pub. Number AU-B-2005231478

PCT Pub. Number WO2005/097160

Priority 60/559,919 05.04.04 US; 60/659,678 07.03.05 US; 60/576,242 01.06.04 US

Filing date 5 April 2005

Wipo publication date 20 October 2005

Acceptance publication date 30 October 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097160 Priority application(s): WO2005/097160

30 October 2008 Application Accepted

  Published as AU-B-2005231478

18 December 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 03 Dec 2008. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden ACT 2606

9 April 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 Dec 2008

23 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005231479-(R,R)-formoterol in combination with other pharmacological agents

2005231476-Il-28 and il-29 cysteine mutants for treating viral infection